Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma.

Pathogenic gene fusions have been identified in several histologic types of salivary gland neoplasia, but not previously in acinic cell carcinoma (AcCC). To discover novel gene fusions, we performed whole-transcriptome sequencing surveys of three AcCC archival cases. In one specimen we identified a...

Full description

Bibliographic Details
Main Authors: Nicholas Barasch, Xue Gong, Kevin A Kwei, Sushama Varma, Jewison Biscocho, Kunbin Qu, Nan Xiao, Joseph S Lipsick, Robert J Pelham, Robert B West, Jonathan R Pollack
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5315303?pdf=render
_version_ 1818499806132174848
author Nicholas Barasch
Xue Gong
Kevin A Kwei
Sushama Varma
Jewison Biscocho
Kunbin Qu
Nan Xiao
Joseph S Lipsick
Robert J Pelham
Robert B West
Jonathan R Pollack
author_facet Nicholas Barasch
Xue Gong
Kevin A Kwei
Sushama Varma
Jewison Biscocho
Kunbin Qu
Nan Xiao
Joseph S Lipsick
Robert J Pelham
Robert B West
Jonathan R Pollack
author_sort Nicholas Barasch
collection DOAJ
description Pathogenic gene fusions have been identified in several histologic types of salivary gland neoplasia, but not previously in acinic cell carcinoma (AcCC). To discover novel gene fusions, we performed whole-transcriptome sequencing surveys of three AcCC archival cases. In one specimen we identified a novel HTN3-MSANTD3 gene fusion, and in another a novel PRB3-ZNF217 gene fusion. The structure of both fusions was consistent with the promoter of the 5' partner (HTN3 or PRB3), both highly expressed salivary gland genes, driving overexpression of full-length MSANTD3 or ZNF217. By fluorescence in situ hybridization of an expanded AcCC case series, we observed MSANTD3 rearrangements altogether in 3 of 20 evaluable cases (15%), but found no additional ZNF217 rearrangements. MSANTD3 encodes a previously uncharacterized Myb/SANT domain-containing protein. Immunohistochemical staining demonstrated diffuse nuclear MSANTD3 expression in 8 of 27 AcCC cases (30%), including the three cases with MSANTD3 rearrangement. MSANTD3 displayed heterogeneous expression in normal salivary ductal epithelium, as well as among other histologic types of salivary gland cancer though without evidence of translocation. In a broader survey, MSANTD3 showed variable expression across a wide range of normal and neoplastic human tissue specimens. In preliminary functional studies, engineered MSANTD3 overexpression in rodent salivary gland epithelial cells did not enhance cell proliferation, but led to significant upregulation of gene sets involved in protein synthesis. Our findings newly identify MSANTD3 rearrangement as a recurrent event in salivary gland AcCC, providing new insight into disease pathogenesis, and identifying a putative novel human oncogene.
first_indexed 2024-12-10T20:34:35Z
format Article
id doaj.art-614af5fbee1a4ef991eedc4a5ab3af7a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T20:34:35Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-614af5fbee1a4ef991eedc4a5ab3af7a2022-12-22T01:34:35ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01122e017126510.1371/journal.pone.0171265Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma.Nicholas BaraschXue GongKevin A KweiSushama VarmaJewison BiscochoKunbin QuNan XiaoJoseph S LipsickRobert J PelhamRobert B WestJonathan R PollackPathogenic gene fusions have been identified in several histologic types of salivary gland neoplasia, but not previously in acinic cell carcinoma (AcCC). To discover novel gene fusions, we performed whole-transcriptome sequencing surveys of three AcCC archival cases. In one specimen we identified a novel HTN3-MSANTD3 gene fusion, and in another a novel PRB3-ZNF217 gene fusion. The structure of both fusions was consistent with the promoter of the 5' partner (HTN3 or PRB3), both highly expressed salivary gland genes, driving overexpression of full-length MSANTD3 or ZNF217. By fluorescence in situ hybridization of an expanded AcCC case series, we observed MSANTD3 rearrangements altogether in 3 of 20 evaluable cases (15%), but found no additional ZNF217 rearrangements. MSANTD3 encodes a previously uncharacterized Myb/SANT domain-containing protein. Immunohistochemical staining demonstrated diffuse nuclear MSANTD3 expression in 8 of 27 AcCC cases (30%), including the three cases with MSANTD3 rearrangement. MSANTD3 displayed heterogeneous expression in normal salivary ductal epithelium, as well as among other histologic types of salivary gland cancer though without evidence of translocation. In a broader survey, MSANTD3 showed variable expression across a wide range of normal and neoplastic human tissue specimens. In preliminary functional studies, engineered MSANTD3 overexpression in rodent salivary gland epithelial cells did not enhance cell proliferation, but led to significant upregulation of gene sets involved in protein synthesis. Our findings newly identify MSANTD3 rearrangement as a recurrent event in salivary gland AcCC, providing new insight into disease pathogenesis, and identifying a putative novel human oncogene.http://europepmc.org/articles/PMC5315303?pdf=render
spellingShingle Nicholas Barasch
Xue Gong
Kevin A Kwei
Sushama Varma
Jewison Biscocho
Kunbin Qu
Nan Xiao
Joseph S Lipsick
Robert J Pelham
Robert B West
Jonathan R Pollack
Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma.
PLoS ONE
title Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma.
title_full Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma.
title_fullStr Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma.
title_full_unstemmed Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma.
title_short Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma.
title_sort recurrent rearrangements of the myb sant like dna binding domain containing 3 gene msantd3 in salivary gland acinic cell carcinoma
url http://europepmc.org/articles/PMC5315303?pdf=render
work_keys_str_mv AT nicholasbarasch recurrentrearrangementsofthemybsantlikednabindingdomaincontaining3genemsantd3insalivaryglandaciniccellcarcinoma
AT xuegong recurrentrearrangementsofthemybsantlikednabindingdomaincontaining3genemsantd3insalivaryglandaciniccellcarcinoma
AT kevinakwei recurrentrearrangementsofthemybsantlikednabindingdomaincontaining3genemsantd3insalivaryglandaciniccellcarcinoma
AT sushamavarma recurrentrearrangementsofthemybsantlikednabindingdomaincontaining3genemsantd3insalivaryglandaciniccellcarcinoma
AT jewisonbiscocho recurrentrearrangementsofthemybsantlikednabindingdomaincontaining3genemsantd3insalivaryglandaciniccellcarcinoma
AT kunbinqu recurrentrearrangementsofthemybsantlikednabindingdomaincontaining3genemsantd3insalivaryglandaciniccellcarcinoma
AT nanxiao recurrentrearrangementsofthemybsantlikednabindingdomaincontaining3genemsantd3insalivaryglandaciniccellcarcinoma
AT josephslipsick recurrentrearrangementsofthemybsantlikednabindingdomaincontaining3genemsantd3insalivaryglandaciniccellcarcinoma
AT robertjpelham recurrentrearrangementsofthemybsantlikednabindingdomaincontaining3genemsantd3insalivaryglandaciniccellcarcinoma
AT robertbwest recurrentrearrangementsofthemybsantlikednabindingdomaincontaining3genemsantd3insalivaryglandaciniccellcarcinoma
AT jonathanrpollack recurrentrearrangementsofthemybsantlikednabindingdomaincontaining3genemsantd3insalivaryglandaciniccellcarcinoma